| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |